For example, IGF2BP2 enhances the stability of tuberous sclerosis complex 1 (TSC1) and peroxisome proliferator-activated receptor gamma (PPAR-γ) mRNAs, promoting an anti-inflammatory response in IBD but a pro-inflammatory response in allergic lung inflammation (68). Here, PPARG is linked to inflammatory bowel disease.